Hubei Gedian Humanwell Pharmaceutical Co., Ltd

Hubei Gedian Renfu Pharmaceutical Co., Ltd. (www.gdrfyy.com) is a pharmaceutical company wholly owned by the listed company Renfu Pharmaceutical Group Co., Ltd. (stock code: 600079, 36th in the "Top 100 Pharmaceutical Industries in China", top 50 in the "Core Competitiveness Ranking of Pharmaceutical Listed Companies", and first in the "Top Ten Pharmaceutical Manufacturers in Hubei Province"). It is specialized in the research, development, production and sales of steroid APIs, reproductive health drugs and anti-tumor drugs. It is located in the Gedian Economic and Technological Development Zone in the suburbs of Wuhan. The company's factory covers an area of ​​80,000 square meters, with a construction area of ​​15,000 square meters, a registered capital of 128.255 million yuan, total assets of 390 million yuan, and annual sales of 300 million yuan. The company is one of the first national technology enterprises to be recognized. It has advanced comprehensive laboratories and professional pharmaceutical research centers. It has independently developed a number of new drug varieties and has good technical reserves and strong R&D capabilities. In recent years, Gedian Renfu Pharmaceutical has been committed to building a complete industrial chain in the field of reproductive health, and has invested in and built 6 subsidiaries focusing on steroid hormone drugs and various special directions in the field of reproductive health industry: Among them, Wuhan Renfu Medical Equipment Co., Ltd. (registered capital of 20 million yuan) focuses on the marketing, sales and after-sales service of international cutting-edge medical equipment and medical device products, and completes the deepening of the field of reproductive health medical devices; Wuhan Jiulong Renfu Pharmaceutical Co., Ltd. (registered capital of 50.08 million yuan, covering an area of ​​71,928 square meters) has built a fertility regulation drug production base with family planning drugs as its leading products, and its profit level and product scale rank among the top three in the country; Hubei Renfu Huachi Pharmaceutical Chemical Co., Ltd. (registered capital of 10 million yuan) is engaged in the production of upstream raw materials for steroid hormones, saponin dienes and their pharmaceutical intermediates Production and sales, committed to becoming the mainstream supplier of saponin diene series products in China and even the world, and strive to become the leader in the production and sales of pharmaceutical chemical raw materials; Hubei Zhuxi Renfu Pharmaceutical Co., Ltd. (registered capital of 10 million yuan, covering an area of ​​74,659 square meters), engaged in the production and sales of pharmaceutical intermediates, chemical products, and plant extracts, and strive to become the mainstream supplier of saponin and its derivatives in China and the world; Hubei Gedian Renfu Pharmaceutical Excipients Co., Ltd. (registered capital of 50 million yuan, covering an area of ​​66,600 square meters), specializes in the research and development, production and sales of pharmaceutical excipients; Wuhan Jiulong Pharmaceutical Co., Ltd. (registered capital of 10 million yuan), relying on the resource advantages of Donghu Free Trade Zone, with the help of Gedian Renfu's expansion and extension of existing product lines, gradually becomes a modern and advanced commercial platform for the "external introduction and internal extension" of the pharmaceutical industry cluster in the central and southern regions. The company currently has 800 employees and a marketing team with a total of more than 300 people. The marketing network covers 26 provinces, cities, autonomous regions and municipalities across the country. The company is actively expanding its overseas business in Southeast Asia, the European Union, South America, the Middle East and Africa. The sunny, energetic, positive, young and efficient team of employees, strong R&D capabilities and increasingly improved domestic and overseas marketing networks have established a good corporate image among the society and the pharmaceutical industry, and have won the trust and support of all sectors of society. The company focuses on the field of human reproductive health and has gradually developed into a banner of China's steroidal family planning drug industry. A carrier in the field of steroid hormone drugs and reproductive health industry is setting sail.